✦ LIBER ✦

Allogeneic stem cell transplantation (SCT) using reduced intensity conditioning (RIC) in the patients with recurrent and refractory malignant lymphoproliferative disorders

✍ Scribed by L. Raida; E. Faber; T. Papajik; K. Indrak; J. Zapletalova; A. Vitek; V. Koza

Book ID: 116278178
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 53 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.12.222

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of Allogeneic Peripheral Blo

Feasibility of Allogeneic Peripheral Blood Stem Cell Transplantation (Allo-SCT) Following Reduced Intensity Conditioning (RIC) in HIV+ Patients with Hematological Malignancies

✍ M. Hamadani; R. Baiocchi; T. Lin; K.A. Blum; S. Ezzone; D.M. Benson Jr.; S.M. De 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Reduced intensity (RI) conditioning and

Reduced intensity (RI) conditioning and allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with non-malignant disorders

✍ D.A. Jacobsohn; M. Kletzel; R. Duerst 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The role of reduced-intensity conditioni

The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison

✍ H. De Lavallade; M. Mohty; C. Faucher; N. Vey; D. Coso; A.M. Stoppa; J.A. Gastau 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Ibritumomab tiuxetan (Zevalin) in the co

Ibritumomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation (SCT) in patients with chemo-refractory non-hodgkin’s lymphoma

✍ A. Shimoni; T. Zwass; Y. Oksman; I. Hardan; N. Shem-Tov; R. Yerushalmi; A. Avigd 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Ibritumomab tiuxetan (Zevalin) combined

Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma

✍ Shimoni, A; Zwas, S T; Oksman, Y; Hardan, I; Shem-Tov, N; Rand, A; Yerushalmi, R 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Allogenic hematopoietic stem-cell transp

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma : Long-term follow-up

✍ Avichai Shimoni; Izhar Hardan; Francis Ayuk; Georgia Schilling; Djorde Atanackov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (SCT) with myeloablative conditioning is potentially curative therapy for myeloma, but is reportedly associated with a high risk of nonrecurrence mortality (NRM). Reduced‐intensity conditioning (RIC) allows for the reduction of NRM, b